CD274 and cancer: In cancer cells, PD-L1 can bind with PD-1 of T cellsto suppress the immune response and reduce immunotherapeutic efficacy.523 To improve immunotherapy, antibodies have beenused to block PD-L1/PD-1 binding, and this strategy has resulted insignificantly enhanced cancer treatment efficiencies.